AVENTIS PHARMA = Q/E DECEMBER 2010 (4TH QTR) = RESULTS = AIDED BY OTHER INCOME AND EXTRAORDINARY ITEMS, NPT IS UP HUGELY

Aventis Pharma Limited

NSE Symbol     AVENTIS

AVENTIS PHARMA has declared its stand alone results for the 4th quarter ending December,2010.

Net sales is Rs.287 cr – up by       3.96% from previous qtr  and by 20.84% from corresponding qtr of last year.

Total Expenditure is Rs.271 cr – up by 13.76% from previous qtr and by 20.43% from corresponding qtr of last year.

Profit from operations is Rs.36 cr – down by 34.78% from previous qtr and up by 14.29% from corresponding qtr of last year.

Profit before tax has risen to Rs.46.70 cr compared to rs.68.50 cr in previous qtr and Rs.37.10 cr in corresponding qtr. This is due to higher other income in current qtr.

Current Qtr has Extraordinary Items equal to Rs.(-)75.70 Cr.

This has helped to pep up the Net profit well in current qtr, further.

Net Profit is Rs.105 cr – up by 121.78% from previous qtr and by 303.46% from corresponding qtr – due to the higher other income and extraordinary items.

Thus, Basic EPS after extraordinary items has risen to Rs.45.61, while the same is Rs.12.7 before the extraordinary items.

FOR THE YEAR ENDING DEC,2010 :

Net Sales of Rs. 108500 lacs for year ending on 31-DEC-2010 against Rs. 97440 lacs for the year ending on 31-DEC-2009.

Net Profit / (Loss) of Rs. 23070 lacs for the year ending on 31-DEC-2010 against Rs. 15740 lacs for the year ending on 31-DEC-2009.

RESULTS TABLE :

AVENTIS PHARMA	31-Dec-10	30-Sep-10	31-Dec-09
Net Sales	28650	27560	23710
DIF%1	287	3.96	20.84
Other Operating Income	2070	1800	1960
Incr./decr. in SIT /WIP	-110	-2380	-2360
Raw Materials	12070	9430	7620
Traded Goods	2420	6180	7220
Employees Cost	4550	3940	3820
Depreciation	540	530	440
Other Expenditure	7650	6140	5780
Total Expenditure	27120	23840	22520
DIF %2	271	13.76	20.43
Profit from Operations	3600	5520	3150
DIF %3	36	-34.78	14.29
Other Income5	1360	1330	570
Interest6	290	-	10
Profit before tax	4670	6850	3710
Tax expense	1750	2120	1110
Extraordinary Items	-7570	-	-
Net Profit	10490	4730	2600
DIF %4	105	121.78	303.46
Dividend (%)	510	-	165
Face Value (In Rs	10	10	10
Paid Up Equity	2300	2300	2300
Basic EPS A EI	45.61	20.57	11.31
Diluted EPS A EI	45.61	20.57	11.31
Basic EPS B EI	12.7	20.57	11.31
Diluted EPS B EI	12.7	20.57	11.31
Public Holding (%)	39.6	39.6	39.6

ANNOUNCEMENTS TO THE EXCHANGE

17-02-2011    Aventis Pharma Limited has informed the Exchange that the date from which dividend is payable is on May 02, 2011, if declared at the Annual General Meeting to be held on April 26, 2011. -

16-02-2011    Aventis Pharma Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 16, 2011, inter alia, has recommended: (1) Final Dividend of Rs. 23 per Equity share of Rs. 10 for the year ended December 31, 2010. An Interim dividend of Rs. 4 per Equity share of Rs. 10 had been paid in August 2010. (2) A Special One-time Dividend of Rs. 28 per Equity share of Rs. 10 arising from the profit of the sale of the Company's shareholding in Chiron Behring Vaccines Private Limited.   -

16-02-2011    Aventis Pharma Limited has informed the Exchange regarding the standalone Results for the year ended on 31-DEC-2010 as follows: Net Sales of Rs. 108500 lacs for year ending on 31-DEC-2010 against Rs. 97440 lacs for the year ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 23070 lacs for the year ending on 31-DEC-2010 against Rs. 15740 lacs for the year ending on 31-DEC-2009.       -

27-12-2010    Aventis Pharma Limited has informed the Exchange vide its letter dated December 27, 2010, regarding "Sale of 49% shareholding in Chiron Behring Vaccines Private Limited".

13-12-2010    Aventis Pharma Limited has informed the Exchange vide its letter dated December 13, 2010, regarding "Sale of 49% shareholding in Chiron Behring Vaccines Private Limited".

30-11-2010    Aventis Pharma Limited has informed the Exchange regarding a press release dated November 29, 2010, titled "Sanofi-aventis launches 'I Am A Champ' program to celebrate diabetes control".

 *  *  *  E  N  D   *  *  *